Home > PS Ratio > ORCHID PHARMA

ORCHID PHARMA
PS (Price/Sales) Ratio

The Current P/S Ratio of ORCHID PHARMA is 7.96.

Share Price ₹1,421.3Jan 27,2025
Market Cap ₹7,205.7 Cr
Sales-TTM₹904.8 CrTTM-Consolidated Results
Price/Sales7.96xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for ORCHID PHARMA
Please provide your vote to see the results

Definition & Calculation of PS (Price/Sales) ratio of ORCHID PHARMA

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of ORCHID PHARMA is calculated as :

Current Market Cap [ ₹7,205.7 Cr] as on Jan 27,2025

(/) Sales [ ₹904.8 Cr] based on TTM-Consolidated Results

(=) P/S Ratio [ 7.96x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for ORCHID PHARMA , the investors are currently willing to pay '7.96 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of ORCHID PHARMA !

The chart below summarizes the trend in P/S Ratio of ORCHID PHARMA over the last five years.

Historical PS (Price/Sales) ratio chart of ORCHID PHARMA


PS Ratio Performance Analysis for ORCHID PHARMA

- ORCHID PHARMA 's latest p/e ratio is 7.96x.

- ORCHID PHARMA 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 6.65x.

- ORCHID PHARMA 's operated at median p/e ratio of 2.36x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, ORCHID PHARMA 's p/e ratio peaked in Mar2021 at 22.36x.

- ORCHID PHARMA 's p/e ratio hit its five-year low in Mar2020 of 0x.


How does ORCHID PHARMA 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
ORCHID PHARMA 904.87.967,205.7
SUN PHARMACEUTICAL INDUSTRIES LTD50,307.78.14409,303.0
CIPLA LTD26,512.04.32114,645.0
DR REDDYS LABORATORIES LTD31,229.33.1598,449.5
ZYDUS LIFESCIENCES LTD21,483.54.2691,587.4
DIVIS LABORATORIES LTD8,614.016.65143,389.0
MANKIND PHARMA LTD11,641.08.71101,440.0
TORRENT PHARMACEUTICALS LTD11,302.09.92112,169.0
LUPIN LTD21,431.34.3192,321.3
AUROBINDO PHARMA LTD30,295.02.1866,080.7
ABBOTT INDIA LTD6,066.19.0254,708.4

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs ORCHID PHARMA 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 2.18x
Max industry PS 16.65x
Median industry PS 7.96x
Average industry PS 7.15x



You may also like the below Video Courses